Beirne Wealth Consulting Services’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
|
|||||
|
2025
Q1 | $1.47M | Hold |
|
|||||
|
2024
Q4 | $2.12M | Sell |
|
|||||
|
2024
Q3 | $1.86M | Buy |
|
|||||
|
2024
Q2 | $1.85M | Buy |
|
|||||
|
2024
Q1 | $2.78M | Sell |
|
|||||
|
2023
Q4 | $3.42M | Buy |
|
|||||
|
2023
Q3 | $880K | Hold |
|
|||||
|
2023
Q2 | $880K | Hold |
|
|||||
|
2023
Q1 | $1.05M | Buy |
|
|||||
|
2022
Q4 | $3.9M | Sell |
|
|||||
|
2022
Q3 | $3.61M | Sell |
|
|||||
|
2022
Q2 | $3.33M | Buy |
|
|||||
|
2022
Q1 | $1.12M | Buy |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $1.49M | Sell |
|
|||||
|
2021
Q2 | $1.32M | Buy |
|
|||||
|
2021
Q1 | $1.59M | Buy |
|
|||||
|
2020
Q4 | $860K | Buy |
|